Trial Profile
An Open-label, Randomized Study Evaluating the Long-term Effects of Metoprolol (MET) Versus Nebivolol (NEB) as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2022
Price :
$35
*
At a glance
- Drugs Nebivolol (Primary) ; Metoprolol
- Indications Hypertension
- Focus Therapeutic Use
- 05 Nov 2005 New trial record.